Zollinger-Ellison syndrome medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Zollinger-Ellison syndrome Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Zollinger-Ellison syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Zollinger-Ellison syndrome medical therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Zollinger-Ellison syndrome medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Zollinger-Ellison syndrome medical therapy
CDC on Zollinger-Ellison syndrome medical therapy
Zollinger-Ellison syndrome medical therapy in the news
Blogs on Zollinger-Ellison syndrome medical therapy
Directions to Hospitals Treating Zollinger-Ellison syndrome
Risk calculators and risk factors for Zollinger-Ellison syndrome medical therapy

Medical Therapy

Proton pump inhibitors (such as omeprazole and lansoprazole) and histamine H2-receptor antagonists (such as famotidine and ranitidine) are used to slow down acid secretion. If possible the tumours should be surgically removed, or treated with chemotherapy.

Octreotide can be used to slow down acid secretion.